Caliway Biopharmaceuticals Co., Ltd. (TPEX: 6919)
541.00
-14.00 (-2.52%)
Sep 10, 2024, 2:59 PM CST
Caliway Biopharmaceuticals Market Cap
Caliway Biopharmaceuticals has a market cap or net worth of 75.43 billion as of September 10, 2024. Its market cap has increased by 243.72% in one year.
Market Cap
75.43B
Enterprise Value
72.10B
Revenue
35.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
541.00
Market Cap Chart
Since December 26, 2022, Caliway Biopharmaceuticals's market cap has increased from 7.96B to 75.43B, an increase of 847.75%. That is a compound annual growth rate of 272.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2024 | 75.43B | 183.56% |
Dec 29, 2023 | 26.60B | 253.33% |
Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition